REQUEST A DEMO
Total
USD $0.00
Search more companies

Greenyn Biotechnology Co., Ltd (Taiwan, China)

Main Activities: Food Manufacturing
Full name: Greenyn Biotechnology Co., Ltd Profile Updated: February 22, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Chinese Download a sample report

Greenyn Biotechnology Co., Ltd is an international biotechnology food raw material research and development manufacturer. The company's main products are health food and dietary raw materials. The company was established in 2012 and is headquartered in Taichung, Taiwan.

Headquarters
5F., No. 43, Keya Rd, Daya Dist
Taichung City; Taichung City;

Contact Details: Purchase the Greenyn Biotechnology Co., Ltd report to view the information.

Website: http://greenynbio.com

Basic Information
Total Employees:
Purchase the Greenyn Biotechnology Co., Ltd report to view the information.
Outstanding Shares:
Purchase the Greenyn Biotechnology Co., Ltd report to view the information.
Financial Auditors:
Purchase the Greenyn Biotechnology Co., Ltd report to view the information.
Incorporation Date:
July 18, 2012
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Finance Officer
Ownership Details
Purchase this report to view the information.
16.04%
Purchase this report to view the information.
16.04%
Purchase this report to view the information.
9.98%
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
COMPSON BIOTECH CO., Ltd.
100%
FENGYANG BIOMEDICAL CO., Ltd.
100%
Company Performance
Financial values in the chart are available after Greenyn Biotechnology Co., Ltd report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
15.32%
Total operating revenue
15.56%
Operating profit (EBIT)
-10.16%
EBITDA
-20.02%
Net Profit (Loss) for the Period
-17.05%
Total assets
32%
Total equity
43.64%
Operating Profit Margin (ROS)
-5.46%
Net Profit Margin
-6.31%
Return on Equity (ROE)
-9.05%
Debt to Equity Ratio
2.9%
Quick Ratio
0.96%
Cash Ratio
0.93%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?